Seeking Alpha

Par Pharmaceutical (PRX +1.8%) is trading higher after acquiring rights to three generic...

Par Pharmaceutical (PRX +1.8%) is trading higher after acquiring rights to three generic products from Teva Pharmaceuticals (TEVA -0.5%): fentanyl citrate lozenges, cyclobenzaprine ER capsules and the generic version of Provigil.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|